MedicaidPrior AuthMedium impact
MAB2023110804
Pennsylvania Medicaid (DHS)·PA · Cardiology, Endocrinology, Family Medicine +2 more·Provider Bulletin
Effective date
Jan 8, 2024
We identified it
Jun 20, 2026
Summary
Pennsylvania Medical Assistance (Medicaid) is implementing revised prior authorization requirements for lipotropic medications, specifically PCSK9 inhibitors, ACL inhibitors, and other cholesterol-lowering drugs. New medical necessity guidelines include more detailed requirements for statin failure documentation and ezetimibe trials before approval.
Action Required
By January 8, 2024: Providers prescribing lipotropic medications to Pennsylvania Medicaid patients must update prior authorization documentation to include detailed statin failure history, lipid profiles within 3 months, and ezetimibe trial results. Review new medical necessity guidelines for PCSK9 inhibitors requiring specific cardiovascular disease history or familial hypercholesterolemia diagnosis. Update prior auth request templates to capture required clinical elements.